How much will Ustekinumab be reimbursed in 2024?

Ustekinumab (Ustekinumab)The original drug has been launched in China. It is available in two forms: subcutaneous injection preparation and intravenous infusion preparation. It has passed the relevant regulations of the National Medical Insurance Bureau and is reimbursed by Class B medical insurance, but it is only reimbursed for patients who meet the indications. Specifications The price of each box of 130mg/26ml intravenous preparation may be more than 5,000 yuan, and the price of each box of 90mg/26ml subcutaneous preparation may be more than 8,000 yuan. Different regions have different reimbursement ratios, and there may be slight differences in the price after reimbursement. For specific information, please consult the local medical insurance bureau or hospital.